How Much Did Q Bio Raise?
Funding & Key Investors

Q Bio has secured $83.5M in total capital, with its most recent funding round bringing in $27M. This significant financial backing underscores the company's progress in its mission to revolutionize preventive personalized healthcare through advanced technology.

What is Q Bio?

Q Bio
Business ServicesSoftware TestingHealthcare Services

Q Bio is a pioneering technology firm operating at the confluence of Artificial Intelligence, Physics, and Biology. The company's core objective is to automate the physical examination process, encompassing data collection, triage, and routing. This innovative approach aims to make preventive and personalized healthcare universally accessible. Headquartered in San Carlos, California, Q Bio fosters a dynamic work environment that encourages collaboration and well-being, attracting talent from across the Bay Area.

How much funding has Q Bio raised?

Q Bio has raised a total of $83.5M across 3 funding rounds:

2018

Series A

$16.5M

2020

Series B

$40M

2024

Other Financing Round

$27M

Series A (2018): $16.5M with participation from Khosla Ventures, Andreessen Horowitz, Sea Lane Ventures, and Thirty Five Ventures

Series B (2020): $40M led by Andreessen Horowitz

Other Financing Round (2024): $27M supported by Andreessen Horowitz and Khosla Ventures

Key Investors in Q Bio

Andreessen Horowitz

Founded in 2009, Andreessen Horowitz is a private American venture capital firm that invests in both early-stage start-ups and established growth companies. The company is headquartered in Menlo Park, California.

Khosla Ventures

Khosla Ventures is a venture capital firm focused on investing in technology companies. They are known for backing innovative startups across various sectors.

Sea Lane Ventures

Sea Lane Ventures is an investment firm that supports companies with significant growth potential. Their focus often lies in disruptive technologies and market-leading ventures.

What's next for Q Bio?

The recent major strategic investment in Q Bio signals a critical phase of scaling and market expansion. With substantial enterprise-level funding, the company is poised to accelerate the development and deployment of its automated physical exam technology. This strategic capital infusion is expected to enhance Q Bio's capabilities in AI-driven diagnostics and personalized health routing, solidifying its position as a leader in the future of proactive healthcare.

See full Q Bio company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject ManagementEducationTraining
Accounting for Legal PracticesBusiness Services
Business ServicesResearch & DevelopmentAerospace & DefenseManufacturing
Business ServicesSoftware Testing

Frequently Asked Questions Regarding Q Bio Financial Insights

What are the most recent funding rounds that Q Bio has completed, and what were the funding rounds?
Q Bio has recently completed 3 funding rounds: Other Financing Round on Jul 18, 2024, Series B on Feb 20, 2020, Series A on Jan 1, 2018.
What is the total amount of funding Q Bio has raised to date?
Q Bio has raised a total of $83.5M in funding to date.
How many funding rounds has Q Bio completed?
Q Bio has completed 3 funding rounds.
How much funding did Q Bio raise in its most recent funding round?
Q Bio raised $27M in its most recent funding round.
Who are the lead investors in Q Bio's latest funding round?
The lead investor in Q Bio's latest funding round was Andreessen Horowitz. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Q Bio's history?
The largest funding round in Q Bio's history was $40M.
See more information about Q Bio